The Effect of Statin on Anemia in Patients with Chronic Kidney Disease and End-Stage Kidney Disease: A Systematic Review and Meta-Analysis

Although erythropoietin-stimulating agents are effective in treating anemia in patients with end-stage kidney disease (ESKD) undergoing hemodialysis, some ESKD patients, especially those with inflammation, continue to suffer from anemia. Statin, an inhibitor of hydroxymethylglutaryl-CoA (HMG-CoA) re...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Meng-Hsu, Su, Fu-You, Chang, Hao-Yun, Su, Po-Cheng, Chiu, Li-Yun, Nowicki, Michal, Kao, Chih-Chin, Lin, Yen-Chung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317421/
https://www.ncbi.nlm.nih.gov/pubmed/35887674
http://dx.doi.org/10.3390/jpm12071175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317421/
https://www.ncbi.nlm.nih.gov/pubmed/35887674
http://dx.doi.org/10.3390/jpm12071175

Ejemplares similares